Latest Commercialization News

Provaris Energy has marked significant milestones in Q2 2025 with a key MOU with global shipping leader 'K' LINE and a joint venture formation with Yinson to commercialise proprietary hydrogen and carbon dioxide transport technologies.

Mustera Property Group advances its North Fremantle McCabe Street project with a planned sales launch in Q3 2025, while settling two Forbes Residences units for $4.6 million, underpinning positive cash flow and refinancing benefits.

Pure Hydrogen reports a second consecutive quarter of positive cash flow, expands its international hydrogen vehicle footprint, and secures a 15-year gas project permit in Queensland.

Blue Energy Limited has been awarded two significant Potential Commercial Areas in Queensland, boosting its contingent gas resources, while facing temporary suspension of pilot wells due to mechanical issues. The company is advancing regulatory approvals and exploring capital raising to support its growth.

Constellation Technologies broadens its Callisto Food Safety platform into new sectors and launches innovative IoT products, while managing a modest cash outflow in Q4 2025.

Renascor Resources has achieved provisional development approval for its commercial-scale Battery Anode Material manufacturing facility, alongside significant progress in graphite production and exploration activities. The company maintains a robust cash position of A$105 million as it advances its vertically integrated graphite project.

Swift Networks reports positive FY25 cash flow and EBITDA, secures new mining contracts, and progresses its next-generation Swift Access 2026 platform poised to accelerate growth.

Tissue Repair Limited reports steady progress in its Phase 3 clinical trials for TR987® despite patient recruitment hurdles, while TR Pro+® sales surge and new distribution deals pave the way for international growth.

Clarity Pharmaceuticals has bolstered its cash reserves to approximately $288 million following a $203 million institutional placement, while reporting significant clinical progress across multiple copper-based radiopharmaceutical trials targeting prostate cancer and neuroendocrine tumours.

Cadoux Limited has made significant progress in developing its high purity alumina and rare earths projects, advancing engineering design, customer engagement, and funding strategies during the June 2025 quarter.

Delorean Corporation has marked significant progress in Q4 FY2025, advancing its renewable gas infrastructure and securing crucial regulatory support that could unlock new revenue streams.

Eden Innovations reports a striking 114% year-on-year jump in Q4 US sales of its EdenCrete® products, alongside a 50% annual sales increase and significant debt reduction plans.